Michael Hartmann

Summary

Affiliation: Friedrich Schiller University
Country: Germany

Publications

  1. ncbi Oncological resource allocation in Germany
    Michael Hartmann
    Faculty of Medicine, Friedrich Schiller University of Jena, Germany
    Onkologie 31:85-9. 2008
  2. ncbi Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations
    M Hartmann
    Faculty of Medicine, Friedrich Schiller University of Jena, Germany
    Br J Cancer 89:1405-8. 2003
  3. ncbi Stability of fentanyl/ropivacain preparations for epidural application
    M Hartmann
    Department of Pharmacy, Faculty of Medicine, , Germany
    Pharmazie 58:434-5. 2003
  4. ncbi Report of a user-satisfaction analysis of a service provider for an oncology clinic
    Michael Hartmann
    Apotheke der FSU Jena, Erlanger Allee 101, 07740, Germany
    J Cancer Res Clin Oncol 130:93-8. 2004
  5. ncbi Industry-sponsored economic studies in critical and intensive care versus studies sponsored by nonprofit organizations
    Michael Hartmann
    Faculty of Medicine, Friedrich Schiller University of Jena, Jena, Germany
    J Intensive Care Med 18:265-8. 2003
  6. ncbi How to increase return on investment of the intensive care pharmacist - fear of flying
    Michael Hartmann
    , Pharmacy, Department of Anaesthesiology and Intensive Care, Germany
    Intensive Care Med 32:511-5. 2006
  7. ncbi Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma
    M Fedders
    FSU Hospital Pharmacy, Erlanger Allee 101, 07743 Jena, Germany
    J Cancer Res Clin Oncol 133:619-25. 2007
  8. ncbi [Economic aspects of standardization of modern wound care]
    M Hartmann
    Universitatsklinikum Jena, Erlanger Allee 101, 07747 Jena
    Hautarzt 58:970-4. 2007
  9. ncbi [Is the guideline, "Management of early rheumatoid arthritis," being followed in a rheumatism center?]
    M Hartmann
    Universitatsklinikum Jena, Erlanger Allee 101, 07747 Jena
    Dtsch Med Wochenschr 133:1721-4. 2008
  10. ncbi A comparison between meperidine, clonidine and urapidil in the treatment of postanesthetic shivering
    K R Schwarzkopf
    Department of Anesthesiology and Intensive Care Therapy, University Hospital, Jena, Germany
    Anesth Analg 92:257-60. 2001

Collaborators

Detail Information

Publications29

  1. ncbi Oncological resource allocation in Germany
    Michael Hartmann
    Faculty of Medicine, Friedrich Schiller University of Jena, Germany
    Onkologie 31:85-9. 2008
    ..The aim of our study was, therefore, to determine the resource allocation and to assess the efficiency of oncology in Germany for the period of 2002-2004...
  2. ncbi Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations
    M Hartmann
    Faculty of Medicine, Friedrich Schiller University of Jena, Germany
    Br J Cancer 89:1405-8. 2003
    ....
  3. ncbi Stability of fentanyl/ropivacain preparations for epidural application
    M Hartmann
    Department of Pharmacy, Faculty of Medicine, , Germany
    Pharmazie 58:434-5. 2003
  4. ncbi Report of a user-satisfaction analysis of a service provider for an oncology clinic
    Michael Hartmann
    Apotheke der FSU Jena, Erlanger Allee 101, 07740, Germany
    J Cancer Res Clin Oncol 130:93-8. 2004
    ..We used a questionnaire to assess professional user-satisfaction concerning the quality of services provided by a university hospital pharmacy for an oncology clinic...
  5. ncbi Industry-sponsored economic studies in critical and intensive care versus studies sponsored by nonprofit organizations
    Michael Hartmann
    Faculty of Medicine, Friedrich Schiller University of Jena, Jena, Germany
    J Intensive Care Med 18:265-8. 2003
    ..There was no statistically demonstrable relationship between types of sponsorship and sensitivity analysis performed, publication status, types of economic analysis, or qualitative cost assessment...
  6. ncbi How to increase return on investment of the intensive care pharmacist - fear of flying
    Michael Hartmann
    , Pharmacy, Department of Anaesthesiology and Intensive Care, Germany
    Intensive Care Med 32:511-5. 2006
  7. ncbi Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma
    M Fedders
    FSU Hospital Pharmacy, Erlanger Allee 101, 07743 Jena, Germany
    J Cancer Res Clin Oncol 133:619-25. 2007
    ....
  8. ncbi [Economic aspects of standardization of modern wound care]
    M Hartmann
    Universitatsklinikum Jena, Erlanger Allee 101, 07747 Jena
    Hautarzt 58:970-4. 2007
    ..At the University Hospital Jena, the assortment of hydroactive wound dressings has been optimized, in order to increase acceptance and attain cost advantages...
  9. ncbi [Is the guideline, "Management of early rheumatoid arthritis," being followed in a rheumatism center?]
    M Hartmann
    Universitatsklinikum Jena, Erlanger Allee 101, 07747 Jena
    Dtsch Med Wochenschr 133:1721-4. 2008
    ..It was the aim of this study to examine how and to what extent the external S3 guideline "Management of Early Rheumatoid Arthritis" was applied in a rheumatism center...
  10. ncbi A comparison between meperidine, clonidine and urapidil in the treatment of postanesthetic shivering
    K R Schwarzkopf
    Department of Anesthesiology and Intensive Care Therapy, University Hospital, Jena, Germany
    Anesth Analg 92:257-60. 2001
    ..Meperidine and clonidine were both very effective, whereas urapidil was only effective in 60% of patients treated...
  11. ncbi The effects of urapidil on thermoregulatory thresholds in volunteers
    Harald G Fritz
    Klinik fuer Anaesthesiologie und Intensivtherapie Klinikum and Apotheke des Klinikums, Friedrich Schiller Universitaet, Jena, Germany
    Anesth Analg 94:626-30; table of contents. 2002
    ..IMPLICATIONS: In this study we show that the antihypertensive drug urapidil stops cold-induced shivering and decreases normal thermoregulatory responses, i.e., the thresholds for vasoconstriction and shivering, in awake volunteers...
  12. ncbi [Effect of enteral naloxone on the incidence of gastritis and esophagitis in mechanically ventilated patients]
    W Meissner
    Klinik für Anästhesiologie und Intensivtherapie, Friedrich Schiller Universitat Jena
    Anasthesiol Intensivmed Notfallmed Schmerzther 39:538-41. 2004
    ..Therefore, in a subpopulation of these patients we studied the effect of enteral naloxone on the incidence of mucosal injury in opioid-treated, mechanically ventilated patients...
  13. ncbi Stability of piritramide in patient-controlled analgesia (PCA) solutions
    D Remane
    Institute of Pharmacy, Faculty of Medicine, Friedrich Schiller University, Jena, Germany
    Pharmazie 64:380-1. 2009
    ..Since application duration for patient-controlled analgesia can exceed that limited time, stability was investigated by HPLC. Our results show that these solutions are chemically stable over a time period of 60 days...
  14. ncbi Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression
    J Rodel
    Institute of Medical Microbiology, Friedrich Schiller University of Jena, D 07743 Jena, Germany
    Infect Immun 66:4491-5. 1998
    ..Chlamydial infection inhibited IFN-gamma-induced expression of HLA-DR antigen in the cells. Addition of IFN-beta antibody directly to infected cultures mitigated HLA-DR inhibition, suggesting involvement of produced IFN-beta...
  15. ncbi Stability of alemtuzumab in infusion-bags
    M Kupfer
    Pharmacy of the University Hospital, Friedrich Schiller University, Jena, Germany
    Pharmazie 64:622-3. 2009
    ..The physical and chemical stability of alemtuzumab could be demonstrated for a time-period of 14 days...
  16. ncbi Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis
    J Rodel
    Institute of Medical Microbiology, Friedrich Schiller University of Jena, Germany
    J Rheumatol 25:2161-8. 1998
    ....
  17. ncbi Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts
    J Rodel
    Institute of Medical Microbiology, Friedrich Schiller University of Jena, Germany
    Med Microbiol Immunol 187:205-12. 1999
    ..The increased production of IRF-1 and ISGF3gamma in C. trachomatis-infected synovial fibroblasts may contribute to induction of IFN-beta and IDO...
  18. ncbi Oral naloxone reverses opioid-associated constipation
    W Meissner
    Clinic of Anaesthesiology and Intensive Care, Friedrich Schiller University Jena, D 07740, Jena, Germany
    Pain 84:105-9. 2000
    ..To prevent systemic withdrawal signs, therapy should be started with low doses and patients carefully monitored during titration...
  19. ncbi Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae
    J Rodel
    Institute of Medical Microbiology, Friedrich Schiller University of Jena, D 07740 Jena, Germany
    Infect Immun 68:3635-41. 2000
    ..These findings suggest that chlamydial infection of smooth muscle cells elicits a cytokine response that may contribute to structural remodeling of the airway wall in chronic asthma and to fibrous plaque formation in atherosclerosis...
  20. ncbi [Urapidil for treatment of postanesthetic shivering following general anesthesia. A placebo controlled pilot study]
    H Fritz
    Klinik für Anästhesiologie und Intensivtherapie des Klinikums der Friedrick Schiller Universität
    Anaesthesist 50:406-10. 2001
    ..Postanaesthetic shivering is common during recovery from general anaesthesia. Therefore we studied whether urapidil suppresses postanaesthetic shivering...
  21. ncbi Interferon-beta induction by Chlamydia pneumoniae in human smooth muscle cells
    J Rodel
    Institute of Medical Microbiology, Friedrich Schiller University of Jena, Germany
    FEMS Immunol Med Microbiol 32:9-15. 2001
    ..C. pneumoniae-induced IFN-beta production by SMC may modulate inflammation and tissue remodelling during respiratory and vascular infection...
  22. ncbi Biosurgery supports granulation and debridement in chronic wounds--clinical data and remittance spectroscopy measurement
    Uwe Wollina
    Department of Dermatology and Allergology and Central Pharmacy, Friedrich Schiller University of Jena, Jena, Germany
    Int J Dermatol 41:635-9. 2002
    ..The purpose of this study was to investigate the clinical effects, side-effects, and possible mechanisms of action of biosurgery...
  23. ncbi Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II)
    Katja de With
    Center for Infectious Diseases and Travel Medicine, University Hospital, Hugstetter Strass 55, D-79106 Freiburg, Germany
    Int J Antimicrob Agents 24:213-8. 2004
    ..The established database allows detailed analysis in antibacterial drug use and can be linked to bacterial resistance surveillance databases...
  24. ncbi [Antibiotic Use at German University Hospitals (Project INTERUNI-II). Results for Medical Intensive Care, Hematology-Oncology, and Other Medical Service Areas]
    Katja de With
    , Freiburg
    Med Klin (Munich) 99:347-54. 2004
    ....
  25. ncbi Update on glycopeptide use in german university hospitals
    W V Kern
    Division of Infectious Diseases, Dept of Medicine, Freiburg University Hospital, Hugstetter Strasse 55, D 79106 Freiburg, Germany
    Infection 32:157-62. 2004
    ..5 defined daily doses (DDD)/100 patient days in the subsequent period. In the present study, more recent data on comparative glycopeptide use in German university hospitals were analyzed...
  26. ncbi Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94
    Peter Albers
    Department of Urology, Klinikum Kassel GmbH, Kassel, Germany
    J Clin Oncol 26:2966-72. 2008
    ..Aim of this trial was to prove the advantage of one cycle of bleomycin, etoposide, and cisplatin (BEP) chemotherapy compared with RPLND in terms of recurrence...
  27. ncbi Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group
    Axel Heidenreich
    Department of Urology and Pediatric Urology, Philipps University, Marburg, Germany
    J Urol 169:1710-4. 2003
    ..Primary nerve sparing retroperitoneal lymph node dissection is curative in about 70% of clinical stage I nonseminoma cases with a maximum of 3 positive lymph nodes...
  28. ncbi Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial
    Peter Albers
    Department of Urology, Bonn University, D 53105 Bonn, Germany
    J Clin Oncol 21:1505-12. 2003
    ..To prospectively assess potential risk factors for relapse in clinical stage I nonseminomatous germ cell tumors of the testis (CS I NSGCT)...
  29. ncbi The complete Corynebacterium glutamicum ATCC 13032 genome sequence and its impact on the production of L-aspartate-derived amino acids and vitamins
    Jorn Kalinowski
    Institut für Genomforschung, Universitat Bielefeld, Universitatsstrasse 25, D 33615 Bielefeld, Germany
    J Biotechnol 104:5-25. 2003
    ..As an example for biotechnological application the complete genome sequence was used to reconstruct the metabolic flow of carbon into a number of industrially important products derived from the amino acid L-aspartate...